Prolonged signaling of backbone-modified glucagon-like peptide- 1 analogues with diverse receptor trafficking.

Brian P Cary, Marlies V Hager, Zamara Mariam, Rylie K Morris, Matthew J Belousoff, Giuseppe Deganutti, Patrick M Sexton, Denise Wootten, Samuel H Gellman

    Research output: Contribution to journalArticlepeer-review

    2 Citations (Scopus)
    21 Downloads (Pure)

    Abstract

    Signal duration and subcellular location are emerging as important facets of G protein-coupled receptor (GPCR) function. The glucagon-like peptide-1 receptor (GLP-1R), a clinically relevant class B1 GPCR, stimulates production of the second messenger cyclic adenosine monophosphate (cAMP) upon activation by the native hormone, GLP-1. cAMP production continues after the hormone-receptor complex has been internalized via endocytosis. Here, we report GLP-1 analogues that induce prolonged signaling relative to GLP-1. A single β-amino acid substitution at position 18, with the residue derived from ( , )- -2-aminocyclopentanecarboxylic acid (ACPC), enhances signaling duration with retention of receptor endocytosis. Pairing ACPC at position 18 with a second substitution, α-aminoisobutyric acid (Aib) at position 16, abrogates endocytosis, but prolonged signaling is maintained. Prolonged signaling is sensitive to the structure of the β residue at position 18. Cryoelectron microscopy structures of two GLP-1 analogues bound to the GLP-1R:Gs complex suggest substantial alterations to bound peptide structure and dynamics compared to the GLP-1:GLP-1R:Gs complex. These structural findings strengthen an emerging view that agonist dynamics in the receptor-bound state influence signaling profiles. Our results advance understanding of the structural underpinnings of receptor activation and introduce tools for exploring the impact of spatiotemporal signaling profiles following GLP-1R activation.
    Original languageEnglish
    Article numbere2407574122
    Pages (from-to)e2407574122
    JournalProceedings of the National Academy of Sciences of the United States of America
    Volume122
    Issue number14
    Early online date1 Apr 2025
    DOIs
    Publication statusPublished - 1 Apr 2025

    Bibliographical note

    Publisher Copyright:
    Copyright © 2025 the Author(s).

    Funding

    This work was supported in part by the NIH (R01 GM056414 and its successor R35 GM151985, to S.H.G.). Additional support was provided by the Vilas Trust. P.M.S. (#1154434, #2025694) and D.W. (#1155302, #2026300) are recipients of fellowships from the National Health and Medical Research Council (NHMRC). P.M.S. is the Director and D.W. the Monash University Node leader of the Australian Research Council Industrial Transformation Training Centre for Cryo-electron Microscopy of Membrane Proteins (#IC200100052). This work was funded in part by an NHMRC Program Grant (#1150083) to P.M.S. and NHMRC Ideas Grant (#1184726) to D.W. B.P.C. and R.K.M. were supported in part by graduate fellowships from the US NSF (DGE-1747503). B.P.C. was supported in part by a Biotechnology Training Grant from the National Institute of General Medical Sciences (NIGMS) (T32 GM008349). M.V.H. was supported in part by a Chemical Biology Interface Training Grant from NIGMS (T32 GM008505). We thank Elle Grevstad for helpful discussions and assistance with optical microscopy. Confocal microscopy was performed at the University of Wisconsin-Madison Biochemistry Optical Core, which was established with support from the University of Wisconsin\u2013Madison Department of Biochemistry Endowment. Cryo-EM samples were imaged at the Bio21 Advanced Microscopy Facility (The University of Melbourne). High-performance computing was supported by Monash MASSIVE.

    FundersFunder number
    University of Wisconsin- Madison
    University of Melbourne
    Monash University
    National Health and Medical Research Council
    William F Vilas Trust Estate1154434, 1155302, 2025694, 2026300
    Australian Research Council1150083, 1184726
    National Institute of General Medical SciencesT32 GM008349, T32 GM008505
    National Institutes of HealthR35 GM151985, R01 GM056414
    National Science FoundationDGE-1747503

      Keywords

      • Glucagon-Like Peptide-1 Receptor/metabolism
      • Glucagon-Like Peptide 1/metabolism
      • Humans
      • Endocytosis
      • Signal Transduction
      • Protein Transport
      • HEK293 Cells
      • Cyclic AMP/metabolism
      • Animals
      • Aminoisobutyric Acids/metabolism
      • Cryoelectron Microscopy
      • peptide
      • GLP-1
      • dynamics
      • cryo-EM
      • trafficking

      ASJC Scopus subject areas

      • General

      Fingerprint

      Dive into the research topics of 'Prolonged signaling of backbone-modified glucagon-like peptide- 1 analogues with diverse receptor trafficking.'. Together they form a unique fingerprint.

      Cite this